Show simple item record

dc.contributor.authorJahangiri, R
dc.contributor.authorSoltani, S
dc.contributor.authorBarzegar, A
dc.date.accessioned2018-08-26T08:32:49Z
dc.date.available2018-08-26T08:32:49Z
dc.date.issued2014
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/52343
dc.description.abstractBackground: Inhibition of angiotensin converting enzyme (i.e inhibition of cleaving angiotensin I to the potent vasoconstrictor angiotensin II) leads to the treatment and reduce the risk of cardiovascular diseases. Peptides (synthetic - natural) with ACE inhibitory activity were studied continuously during the last decades and resulting data were applied by medicinal chemists to design and develop new drugs. Their structure and activity/property relationships were studied during these years and different QSAR models were developed which assisted researchers and manufactures to reduce the cost of experiments. Developed models were reviewed in the present paper according to the applied dataset, descriptors, feature selection methods, model development and validation methods. The selected descriptors for different datasets and models were compared and discussed according to the experimental findings. Copyright é 2013 by Tabriz University of Medical Sciences.
dc.language.isoEnglish
dc.relation.ispartofPharmaceutical Sciences
dc.subjectcaptopril
dc.subjectdipeptidyl carboxypeptidase inhibitor
dc.subjectenalapril
dc.subjectfosinopril
dc.subjectramipril
dc.subjectzofenopril
dc.subjectcardiovascular risk
dc.subjectdrug potency
dc.subjectenzyme inhibition
dc.subjecthuman
dc.subjectIC50
dc.subjectprediction
dc.subjectquantitative structure activity relation
dc.subjectReview
dc.subjectrisk factor
dc.titleA review of QSAR studies to predict activity of ACE peptide inhibitors
dc.typeArticle
dc.citation.volume20
dc.citation.issue3
dc.citation.spage122
dc.citation.epage129
dc.citation.indexScopus


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record